Building Quality into Advanced Therapies from Day One
March 13, 2026
Why early, risk-based thinking is critical in cell and gene therapy development
5 min read
False
Advertisement
Outsourcing
Quality Without Complexity: Interviewing Dipesh Patel
February 4, 2026
“Giving people enough space and a safe environment to do their job and innovate is fulfilling for them, and they will then, inevitably, develop solutions to the most pressing needs.”
4 min read
How AI and CDMO/CRO Integration is Key to the Future of Drug Development
By Jennifer Cannon
February 3, 2026
The next era of drug development will be connected, data-driven and centered on patient impact
4 min read
ten23 health and BD Partner to Address Demand for Self-Administered Therapies
January 30, 2026
Partnership enables supply chain readiness of BD Libertas™ wearable injector as full-service solution
1 min read
The Strategic Questions Reshaping the CDMO Map
January 22, 2026
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
9 min read
How Speed, Scale, and Science Can Personalize the Pandemic Response
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
Why Europe’s CDMO Sector Must Learn to Dance with Disruption
By Joe Renny
January 14, 2026
For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.
4 min read
For the Love of Patients: Communicate
By J.D. Mowery
December 4, 2025
So, you’re at the stage where you need a CDMO. Some partnerships work and others fail. Here’s what I’ve learned about trust from my experience.
5 min read
Kindeva at CPHI Frankfurt 2025: Interviewing Milton Boyer
November 13, 2025
We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
Malaria Vaccine Development: Oxford and ReciBioPharm Extend Manufacturing Deal
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
